VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,485,000 | -19.0% | 784,818 | +6.5% | 0.51% | -23.1% |
| Q4 2017 | $15,405,000 | +1.7% | 736,718 | -30.5% | 0.67% | +16.6% |
| Q3 2017 | $15,145,000 | -22.2% | 1,059,318 | -5.5% | 0.57% | -21.3% |
| Q2 2017 | $19,458,000 | +46.3% | 1,121,113 | -7.2% | 0.73% | +41.4% |
| Q1 2017 | $13,304,000 | -7.2% | 1,207,818 | +22.4% | 0.51% | -12.0% |
| Q4 2016 | $14,332,000 | -15.5% | 987,118 | +42.6% | 0.58% | -4.3% |
| Q3 2016 | $16,952,000 | +11.5% | 692,118 | -8.7% | 0.61% | +0.2% |
| Q2 2016 | $15,210,000 | +31.4% | 758,300 | +72.5% | 0.61% | +33.6% |
| Q1 2016 | $11,575,000 | -40.8% | 439,700 | +127.5% | 0.46% | -46.0% |
| Q4 2015 | $19,560,000 | +128.7% | 193,300 | +301.5% | 0.84% | +153.0% |
| Q3 2015 | $8,553,000 | -38.9% | 48,144 | -23.7% | 0.33% | -34.6% |
| Q2 2015 | $14,004,000 | +148.7% | 63,100 | +121.4% | 0.51% | +197.1% |
| Q1 2015 | $5,631,000 | +503.5% | 28,500 | +338.5% | 0.17% | +454.8% |
| Q4 2014 | $933,000 | +72.8% | 6,500 | +58.5% | 0.03% | +14.8% |
| Q1 2014 | $540,000 | -95.7% | 4,100 | -96.2% | 0.03% | -95.8% |
| Q4 2013 | $12,491,000 | -22.1% | 106,500 | -30.6% | 0.64% | -28.7% |
| Q3 2013 | $16,039,000 | +106.6% | 153,500 | +70.0% | 0.90% | +75.9% |
| Q2 2013 | $7,762,000 | – | 90,300 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |